Letter to the Editor

Abstract

Get full access to this article

View all access options for this article.

References

Sanchez-Guerrero J , Liang MH , Karlson EW , Hunter DJ , Colditz GA. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus . Ann Intern Med 1995; 122: 430-433 .

Meier CR , Sturkenboom MC , Cohen AS , Jick H. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus . J Rheumatol 1998; 25: 1515-1519 .

Cooper GS , Dooley MA , Treadwell EL , St. Clair EW , Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus . Arthritis Rheum 2002; 46: 1830-1839 .

Buyon JP , Petri MA , Kim MY et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial . Ann Intern Med 2005; 142: 953-962 .

Walker AM. Confounding by indication . Epidemiology 1996; 7: 335-336 .

Listing J , Strangfeld A , Kary S et al. Infections in patients with rheumatoid arthritis treated with biologic agents . Arthritis Rheum 2005; 52: 3403-3412 .

Khanna D , Park GS , Paulus HE et al. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies . Arthritis Rheum 2005; 52: 3030-3038 .

Rosenbaum PR , Rubin DB. The central role of the propensity score in observational studies for causal effects . Biometrics 1983; 70: 41-55 .

Rubin DB. Estimating causal effects from large data sets using propensity scores . Ann Intern Med 1997; 127: 757-763 .

10.

D’Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group . Statist Med 1998; 17: 2265-2281 .